First Trust Mid Cap Growth AlphaDEX Fund (FNY) is an exchange-traded fund (ETF) listed on the NASDAQ. The most recent ex-dividend date was June 26, 2025, with payment scheduled for June 30, 2025. market capitalization is approximately $600M.
FNY holds 224 positions, with 8.6% of assets in its ten largest. It charges an expense ratio of 0.73%, and manages $567.6M.
| Holding | Weight |
|---|---|
| ZETAZeta Global Holdings Corp. (Class A) | 1.00% |
| HALOHalozyme Therapeutics, Inc. | 0.89% |
| GHGuardant Health, Inc. | 0.88% |
| TPCTutor Perini Corporation | 0.86% |
| CORTCorcept Therapeutics Inc. | 0.86% |
| FTDRFrontdoor, Inc. | 0.84% |
| PACSPACS Group, Inc. | 0.84% |
| GKOSGlaukos Corporation | 0.83% |
| OKTAOkta, Inc. | 0.82% |
| TGTXTG Therapeutics, Inc. | 0.80% |